ERBB2 and cancer: For example, in T-DM1, the antibody trastuzumab binds to the HER2 receptor of cancer cells and inhibits the development of heterodimer between HER2 and HER1, HER3 or HER4, which blocks the signal transduction pathways of cell survival and proliferation to induce the cell apoptosis [14].